XML 64 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:        
Net income (loss) $ 966 $ 795 $ 2,248 $ 1,572
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (402) (395)
Depreciation and amortization 562 521 1,115 1,042
Income taxes     118 267
Losses (gains) on sales of facilities (9) (2) (414) (3)
Amortization of debt issuance costs     15 16
Share-based compensation     134 140
Other     51 45
Net cash provided by (used in) operating activities     2,865 2,684
Cash flows from investing activities:        
Purchase of property and equipment     (1,574) (1,304)
Acquisition of hospitals and health care entities     (538) (295)
Disposition of hospitals and health care entities     799 14
Change in investments     23 (11)
Other     (25) 5
Net cash used in investing activities     (1,315) (1,591)
Cash flows from financing activities:        
Issuance of long-term debt       1,502
Net change in revolving credit facilities     210 (1,160)
Repayment of long-term debt     (101) (95)
Distributions to noncontrolling interests     (185) (248)
Payment of debt issuance costs     (2) (25)
Payment of cash dividends     (245)  
Repurchases of common stock     (893) (966)
Other     (192) (42)
Net cash (used in) provided by financing activities     (1,408) (1,034)
Effect on exchange rate changes on cash and cash equivalents     (6)  
Change in cash and cash equivalents     136 59
Cash and cash equivalents at beginning of period     732 646
Cash and cash equivalents at end of period 868 705 868 705
Eliminations [Member]        
Cash flows from operating activities:        
Net income (loss) (852) (658) (1,942) (1,266)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Equity in earnings of affiliates     1,942 1,266
HCA Healthcare, Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) 820 657 1,964 1,316
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities       1
Income taxes     118 267
Equity in earnings of affiliates     (1,942) (1,266)
Other     43 39
Net cash provided by (used in) operating activities     183 357
Cash flows from financing activities:        
Payment of cash dividends     (245)  
Repurchases of common stock     (893) (966)
Changes in intercompany balances with affiliates, net     1,150 671
Other     (196) (62)
Net cash (used in) provided by financing activities     (184) (357)
Change in cash and cash equivalents     (1)  
Cash and cash equivalents at beginning of period     1  
HCA Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) (666) (476) (1,308) (939)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     2 (189)
Amortization of debt issuance costs     15 16
Net cash provided by (used in) operating activities     (1,291) (1,112)
Cash flows from financing activities:        
Issuance of long-term debt       1,500
Net change in revolving credit facilities     210 (1,160)
Repayment of long-term debt     (41) (42)
Payment of debt issuance costs     (2) (25)
Changes in intercompany balances with affiliates, net     1,124 839
Net cash (used in) provided by financing activities     1,291 1,112
Subsidiary Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 1,306 993 2,876 1,915
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (352) (196)
Depreciation and amortization 329 302 652 612
Losses (gains) on sales of facilities 23 (4) (372) (3)
Share-based compensation     134 140
Other       1
Net cash provided by (used in) operating activities     2,938 2,469
Cash flows from investing activities:        
Purchase of property and equipment     (900) (729)
Acquisition of hospitals and health care entities     (438) (6)
Disposition of hospitals and health care entities     767 10
Change in investments     17  
Other     (30) 2
Net cash used in investing activities     (584) (723)
Cash flows from financing activities:        
Repayment of long-term debt     (38) (33)
Distributions to noncontrolling interests     (43) (79)
Changes in intercompany balances with affiliates, net     (2,188) (1,589)
Net cash (used in) provided by financing activities     (2,269) (1,701)
Change in cash and cash equivalents     85 45
Cash and cash equivalents at beginning of period     112 113
Cash and cash equivalents at end of period 197 158 197 158
Subsidiary Non-Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 358 279 658 546
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (52) (11)
Depreciation and amortization 233 219 463 430
Losses (gains) on sales of facilities (32) 2 (42)  
Other     8 5
Net cash provided by (used in) operating activities     1,035 970
Cash flows from investing activities:        
Purchase of property and equipment     (674) (575)
Acquisition of hospitals and health care entities     (100) (289)
Disposition of hospitals and health care entities     32 4
Change in investments     6 (11)
Other     5 3
Net cash used in investing activities     (731) (868)
Cash flows from financing activities:        
Issuance of long-term debt       2
Repayment of long-term debt     (22) (20)
Distributions to noncontrolling interests     (142) (169)
Changes in intercompany balances with affiliates, net     (86) 79
Other     4 20
Net cash (used in) provided by financing activities     (246) (88)
Effect on exchange rate changes on cash and cash equivalents     (6)  
Change in cash and cash equivalents     52 14
Cash and cash equivalents at beginning of period     619 533
Cash and cash equivalents at end of period $ 671 $ 547 $ 671 $ 547